Functional assays in the diagnosis of heparin-induced thrombocytopenia: A review

Research output: Contribution to journalReview article

Abstract

A rapid and accurate diagnosis in patients with suspected heparin-induced thrombocytopenia (HIT) is essential for patient management but remains challenging. Current HIT diagnosis ideally relies on a combination of clinical information, immunoassay and functional assay results. Platelet activation assays or functional assays detect HIT antibodies that are more clinically significant. Several functional assays have been developed and evaluated in the literature. They differ in the activation endpoint studied; the technique or technology used; the platelet donor selection; the platelet suspension (washed platelets, platelet rich plasma or whole blood); the patient sample (serum or plasma); and the heparin used (type and concentrations). Inconsistencies in controls performed and associated results interpretation are common. Thresholds and performances are determined differently among papers. Functional assays suffer from interlaboratory variability. This lack of standardization limits the evaluation and the accessibility of functional assays in laboratories. In the present article, we review all the current activation endpoints, techniques and methodologies of functional assays developed for HIT diagnosis.

Original languageEnglish
Article number617
JournalMolecules
Volume22
Issue number4
DOIs
Publication statusPublished - 1 Apr 2017

Fingerprint

heparins
platelets
Thrombocytopenia
Heparin
Assays
Platelets
Blood Platelets
activation
Chemical activation
Donor Selection
immunoassay
Platelet-Rich Plasma
Platelet Activation
standardization
antibodies
Immunoassay
serums
Plasmas
blood
Suspensions

Keywords

  • Diagnosis
  • Functional assay
  • Heparin-induced thrombocytopenia
  • Platelets

Cite this

@article{903b9a0f901041afb837a59567693d73,
title = "Functional assays in the diagnosis of heparin-induced thrombocytopenia: A review",
abstract = "A rapid and accurate diagnosis in patients with suspected heparin-induced thrombocytopenia (HIT) is essential for patient management but remains challenging. Current HIT diagnosis ideally relies on a combination of clinical information, immunoassay and functional assay results. Platelet activation assays or functional assays detect HIT antibodies that are more clinically significant. Several functional assays have been developed and evaluated in the literature. They differ in the activation endpoint studied; the technique or technology used; the platelet donor selection; the platelet suspension (washed platelets, platelet rich plasma or whole blood); the patient sample (serum or plasma); and the heparin used (type and concentrations). Inconsistencies in controls performed and associated results interpretation are common. Thresholds and performances are determined differently among papers. Functional assays suffer from interlaboratory variability. This lack of standardization limits the evaluation and the accessibility of functional assays in laboratories. In the present article, we review all the current activation endpoints, techniques and methodologies of functional assays developed for HIT diagnosis.",
keywords = "Diagnosis, Functional assay, Heparin-induced thrombocytopenia, Platelets",
author = "Valentine Minet and Dogn{\'e}, {Jean Michel} and Fran{\cc}ois Mullier",
year = "2017",
month = "4",
day = "1",
doi = "10.3390/molecules22040617",
language = "English",
volume = "22",
journal = "Molecules",
issn = "1431-5165",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "4",

}

Functional assays in the diagnosis of heparin-induced thrombocytopenia : A review. / Minet, Valentine; Dogné, Jean Michel; Mullier, François.

In: Molecules, Vol. 22, No. 4, 617, 01.04.2017.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Functional assays in the diagnosis of heparin-induced thrombocytopenia

T2 - A review

AU - Minet, Valentine

AU - Dogné, Jean Michel

AU - Mullier, François

PY - 2017/4/1

Y1 - 2017/4/1

N2 - A rapid and accurate diagnosis in patients with suspected heparin-induced thrombocytopenia (HIT) is essential for patient management but remains challenging. Current HIT diagnosis ideally relies on a combination of clinical information, immunoassay and functional assay results. Platelet activation assays or functional assays detect HIT antibodies that are more clinically significant. Several functional assays have been developed and evaluated in the literature. They differ in the activation endpoint studied; the technique or technology used; the platelet donor selection; the platelet suspension (washed platelets, platelet rich plasma or whole blood); the patient sample (serum or plasma); and the heparin used (type and concentrations). Inconsistencies in controls performed and associated results interpretation are common. Thresholds and performances are determined differently among papers. Functional assays suffer from interlaboratory variability. This lack of standardization limits the evaluation and the accessibility of functional assays in laboratories. In the present article, we review all the current activation endpoints, techniques and methodologies of functional assays developed for HIT diagnosis.

AB - A rapid and accurate diagnosis in patients with suspected heparin-induced thrombocytopenia (HIT) is essential for patient management but remains challenging. Current HIT diagnosis ideally relies on a combination of clinical information, immunoassay and functional assay results. Platelet activation assays or functional assays detect HIT antibodies that are more clinically significant. Several functional assays have been developed and evaluated in the literature. They differ in the activation endpoint studied; the technique or technology used; the platelet donor selection; the platelet suspension (washed platelets, platelet rich plasma or whole blood); the patient sample (serum or plasma); and the heparin used (type and concentrations). Inconsistencies in controls performed and associated results interpretation are common. Thresholds and performances are determined differently among papers. Functional assays suffer from interlaboratory variability. This lack of standardization limits the evaluation and the accessibility of functional assays in laboratories. In the present article, we review all the current activation endpoints, techniques and methodologies of functional assays developed for HIT diagnosis.

KW - Diagnosis

KW - Functional assay

KW - Heparin-induced thrombocytopenia

KW - Platelets

UR - http://www.scopus.com/inward/record.url?scp=85019655394&partnerID=8YFLogxK

U2 - 10.3390/molecules22040617

DO - 10.3390/molecules22040617

M3 - Review article

C2 - 28398258

AN - SCOPUS:85019655394

VL - 22

JO - Molecules

JF - Molecules

SN - 1431-5165

IS - 4

M1 - 617

ER -